StonvexLoading…
StonvexStonvexStonvexCore line items from DOCS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Annual 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $499.49M | $314.44M | $145.91M | $570.40M |
Operating Income | $190.09M | $118.20M | $54.52M | $227.80M |
Net Income | $176.94M | $115.38M | $53.32M | $223.19M |
EPS (Diluted) | $0.88 | $0.57 | $0.27 | $1.11 |
Total Assets | $1.16B | $1.26B | $1.20B | $1.26B |
Total Liabilities | $177.73M | $161.58M | $178.85M | $181.68M |
Cash & Equivalents | $64.84M | $169.25M | $137.26M | $209.61M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | $273.26M |
Shares Outstanding | 184.99M | 188.09M | 187.45M | 188.88M |